About Us
Corporate Profile
Management Team
Board of Directors
Scientific Advisory Board
Our Platform
Our Programs
Conjugate Vaccines
Lead Program: PCV
Pipeline
Posters / Publications
Investors & Media
Overview
Press Releases
Events & Presentations
Corporate Governance
Governance Overview
Board of Directors
Management
Committee Composition
Financials & Filings
Stock Information
Stock Quote & Chart
Historic Price Lookup
Analyst Coverage
Investor Resources
Investor FAQs
Email Alerts
IR Contact
Tax Disclosures
Careers
Contact
Posters / Publications
VAX-A1
Research Article,
Infectious Microbes & Diseases
, December 2020; click to view
“
Site-Specific Conjugation of Cell Wall Polyrhamnose to Protein SpyAD Envisioning a Safe Universal Group A Streptococcal Vaccine
“
About Us
Corporate Profile
Management Team
Board of Directors
Scientific Advisory Board
Our Platform
Our Programs
Conjugate Vaccines
Lead Program: PCV
Pipeline
Posters / Publications
Investors & Media
Overview
Press Releases
Events & Presentations
Corporate Governance
Governance Overview
Board of Directors
Management
Committee Composition
Financials & Filings
Stock Information
Stock Quote & Chart
Historic Price Lookup
Analyst Coverage
Investor Resources
Investor FAQs
Email Alerts
IR Contact
Tax Disclosures
Careers
Contact
SutroVax Announces
Name Change to Vaxcyte
Learn More
×